Pentostatin and Lorazepam drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Pentostatin (pentostatin) and Lorazepam (lorazepam). Common drug interactions include hyperglycaemia among females and anaemia among males.

The phase IV clinical study analyzes what interactions people have when they take Pentostatin and Lorazepam. It is created by eHealthMe based on reports of 13 people who take the same drugs from the FDA, and is updated regularly.

What is Pentostatin?

Pentostatin has active ingredients of pentostatin. eHealthMe is studying from 833 Pentostatin users. Check the latest studies of Pentostatin.

What is Lorazepam?

Lorazepam has active ingredients of lorazepam. It is often used in stress and anxiety. eHealthMe is studying from 165,639 Lorazepam users. Check the latest studies of Lorazepam.

On Jul, 15, 2026

13 people who take Pentostatin and Lorazepam together, and have interactions are studied.

Pentostatin and Lorazepam drug interactions.

What are the common drug interactions of Pentostatin and Lorazepam, by gender? *:

female:

Hyperglycaemia (high blood sugar)
Hypernatraemia (an abnormally high plasma concentration of sodium ions)
Malnutrition (a condition that results from eating a diet in which certain nutrients are lacking)
Pulmonary alveolar haemorrhage (acute bleeding)
Respiratory acidosis (respiratory failure or ventilatory failure, causes the ph of blood and other bodily fluids to decrease)
Respiratory arrest (cessation of normal respiration due to failure of the lungs to function effectively)
White blood cell count decreased
Ascites (accumulation of fluid in the abdominal cavity)
Bacterial infection
Blood lactate dehydrogenase increased

male:

Anaemia (lack of blood)
Dyspnoea at rest (difficult or laboured breathing during rest)
Haemothorax (collection of blood in the pleural space (the space between the lungs and the walls of the chest))
Pneumonia

What are the common drug interactions of Pentostatin and Lorazepam, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

Ascites (accumulation of fluid in the abdominal cavity)
Bacterial infection
Cholangitis (infection of the bile duct)
Cholecystitis (infection of gallbladder)
Hepatic failure (liver failure)
Hepatitis (inflammation of the liver)
Hypotension (abnormally low blood pressure)
Lung neoplasm (tumour of lung)
Pancreatitis (inflammation of pancreas)
Pleural effusion (water on the lungs)

20-29:

n/a

30-39:

n/a

40-49:

Pneumonia
Respiratory failure (inadequate gas exchange by the respiratory system)
Respiratory syncytial virus infection (viral disease of respiratory system)
Acute respiratory distress syndrome
Anaemia (lack of blood)
Hyperglycaemia (high blood sugar)
Hypernatraemia (an abnormally high plasma concentration of sodium ions)
Hypotension (abnormally low blood pressure)
Malnutrition (a condition that results from eating a diet in which certain nutrients are lacking)
Pulmonary alveolar haemorrhage (acute bleeding)

50-59:

n/a

60+:

Anaemia (lack of blood)
Dyspnoea at rest (difficult or laboured breathing during rest)
Nausea (feeling of having an urge to vomit)
Tumour lysis syndrome (a group of metabolic complications that can occur after treatment of cancer, these complications are caused by the breakdown products of dying cancer cells)
Vomiting
White blood cell count decreased
Haemothorax (collection of blood in the pleural space (the space between the lungs and the walls of the chest))
Pneumonia
Blood lactate dehydrogenase increased
Body temperature increased

What are the existing conditions these people have? *

T-Cell Prolymphocytic Leukaemia (a aggressive type of t cell cancer): 2 people, 15.38%
Prolymphocytic Leukaemia (cancer of the blood or bone marrow characterized by an abnormal increase of immature white blood cells): 1 person, 7.69%
Haematological Malignancy (cancer that affect blood, bone marrow, and lymph nodes): 1 person, 7.69%
Graft Versus Host Disease (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the body): 1 person, 7.69%
Chronic Lymphocytic Leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell)): 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Pentostatin and Lorazepam?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously